Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious diseases. Our medicines reach more than 250 million people worldwide.
Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, and Instagram.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. For more than 25 years, PTC has been successful in bringing ground-breaking therapies to patients across multiple rare disorders, globally. Our research and innovation continue to expand as we discover and develop novel treatments using the newest scientific platforms and technologies. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, LinkedIn, Twitter and Instagram
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines. Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. ss
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions
Versalya Pharma, established in 2012 and headquartered in Alcobendas, Madrid, is a European pharmaceutical company and affiliate of the Italfarmaco Group. The company supports the Group’s expansion across Africa and the Middle East, focusing on prescription and OTC therapies for women and children. Founded in 1938, Italfarmaco is a privately owned organization with expertise spanning oncology, cardiology, neurology, and women’s health. More recently, the Group has expanded into rare diseases, with a focus on Duchenne muscular dystrophy, reinforcing its commitment to addressing unmet medical needs through innovation and specialized care.
Vertex is a global biotechnology company focused on scientific innovation to develop transformative medicines for serious diseases. It has approved therapies addressing the underlying cause of cystic fibrosis and gene therapies for sickle cell disease and transfusion-dependent beta thalassemia. Its pipeline includes investigational small molecules and mRNA for acute and neuropathic pain, AMKD, type 1 diabetes, and AATD. Founded in 1989 in Cambridge, Massachusetts, Vertex is headquartered in Boston, with international headquarters in London and offices worldwide. It is also recognised as a top workplace. Visit www.vrtx.com for company updates and Vertex’s history of innovation

Copyrights 2026 | 6th Annual MENA Metabolic & Genetic Conference™ | All Rights Reserved